Biocon Q4 Results

  • BSE: 532523
  • NSE: BIOCON
  • ISIN: INE376G01013
  • Sector: Biotechnology & Drugs
BSE
336.355.15 (1.55%)
Volume46.91 K
Updated: Mon 25 Nov, 2024 | 15:29:37
NSE
336.354.85 (1.46%)
Volume1.45 M
Updated: Mon 25 Nov, 2024 | 15:44:41
Today: 333.65
338.90
52-Wk: 231.35
395.65

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Biocon Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 3,917.102,941.10-%3,773.90-%
    Selling/ General/ Admin Expenses Total 741.60558.80-%569.30-%
    Depreciation/ Amortization 407.00301.10-%363.70-%
    Other Operating Expenses Total 930.10758.40-%978.50-%
    Total Operating Expense 3,417.002,869.30-%3,143.30-%
    Operating Income 500.1071.80-%630.60-%
    Net Income Before Taxes 319.00-25.50-%496.60-%
    Net Income 135.50-41.80-%313.20-%
    Diluted Normalized EPS 1.181.13-%2.64-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts